425: Strive Acquires Semler Scientific in All-Stock Bitcoin Treasury Merger

Strive, Inc. announced a definitive agreement to acquire Semler Scientific, Inc. in an all-stock transaction, creating a combined entity with over 10,900 Bitcoin holdings.

Summary

• Strive, Inc. has entered into a definitive agreement to acquire Semler Scientific, Inc. in an all-stock transaction, aiming to create a leading Bitcoin treasury and preventative diagnostics company.
• Strive recently purchased 5,816 Bitcoin for a total of $675,000,000, at an average price of $116,047 per Bitcoin, increasing its total Bitcoin holdings to 5,886.
• The deal offers Semler Scientific shareholders an approximately 210% premium, equivalent to about $90.52 per share, based on market close prices on September 19, 2025.
• Each common share of Semler Scientific will be exchanged for 21.05 Class A common shares of Strive.
• The combined company is projected to own over 10,900 Bitcoin and plans to explore monetizing or distributing Semler Scientific's diagnostics business at a future date.
• The combined entity intends to operate with a preferred equity-only leverage model to mitigate debt maturity risks associated with traditional leveraged Bitcoin strategies.
• The boards of directors of both Strive and Semler Scientific have unanimously approved the transaction, which remains subject to customary closing conditions.

Sentiment

Score: 8

Explanation: The filing announces a strategic merger with a significant premium for the acquired company, substantial Bitcoin holdings, and a clear growth strategy for both Bitcoin accumulation and the diagnostics business. While there are standard merger risks and dilution for Strive shareholders, the overall tone and stated objectives are highly positive and growth-oriented.

Positives

• Semler Scientific shareholders will receive a substantial premium of approximately 210%, or $90.52 per share, based on recent market prices.
• The merger creates a scaled Bitcoin acquisition platform, positioning the combined company as a top Bitcoin treasury holder with over 10,900 Bitcoin.
• The combined company aims to become the fastest-growing corporate Bitcoin holder, with a strategy to outperform Bitcoin over the long run.
• Strive's preferred equity-only leverage model is designed to avoid debt maturity risks associated with traditional leveraged Bitcoin strategies.
• The transaction is expected to drive equity value accretion by growing Bitcoin holdings and Bitcoin per share at an unmatched pace in the industry.
• Semler Scientific's medical diagnostics business will be expanded into a robust preventative care and wellness platform, focusing on early detection of chronic disease.
• Eric Semler, Executive Chairman of Semler Scientific, is expected to join the Board of Directors of the combined company, providing continuity and expertise.

Negatives

• The transaction is subject to customary closing conditions, meaning its completion is not yet guaranteed.
• Strive's issuance of additional Class A common stock in connection with the transaction will result in dilution for existing Strive shareholders.
• There is a risk that the anticipated benefits of the proposed transaction, including cost savings and strategic gains, may not be fully realized.
• The integration of the two companies may prove more difficult, time-consuming, or costly than initially expected.
• Management's attention may be diverted from ongoing business operations and opportunities during the merger process.
• Potential adverse reactions from customers or changes to business or employee relationships could occur as a result of the announcement or completion of the transaction.
• Changes in Strive's or Semler Scientific's share price before closing could impact the final value of the deal.

Risks

• The occurrence of any event, change, or other circumstances that could give rise to the right of one or both parties to terminate the merger agreement.
• The possibility that the proposed transaction does not close when expected or at all because the conditions to closing are not received or satisfied on a timely basis or at all.
• The outcome of any legal proceedings that may be instituted against Strive, Semler Scientific, or the combined company.
• The possibility that the anticipated benefits of the proposed transaction, including anticipated cost savings and strategic gains, are not realized when expected or at all, including as a result of changes in, or problems arising from, implementation of Bitcoin treasury strategies and risks associated with Bitcoin and other digital assets, general economic and market conditions, interest and exchange rates, monetary policy, and laws and regulations and their enforcement.
• The possibility that the integration of the two companies may be more difficult, time-consuming, or costly than expected.
• The proposed transaction may be more expensive or take longer to complete than anticipated, including as a result of unexpected factors or events.
• The diversion of management's attention from ongoing business operations and opportunities.
• Dilution caused by Strive's issuance of additional shares of its Class A common stock in connection with the proposed transaction.
• Potential adverse reactions of Strive's or Semler Scientific's customers or changes to business or employee relationships, including those resulting from the announcement or completion of the proposed transaction.
• Changes in Strive's or Semler Scientific's share price before closing.

Future Outlook

The combined company intends to explore monetizing or distributing Semler Scientific's historically profitable diagnostics business at a future date, with a new management team and an expanded mandate in preventative diagnostics. It also aims to become the fastest-growing corporate Bitcoin holder, operating with a preferred equity-only leverage model to avoid debt maturity risks, and plans to acquire additional Bitcoin from future financings.

Management Comments

• "This merger cements Strive's position as a top Bitcoin treasury company, and we believe our alpha-seeking strategies and capital structure position us to outperform Bitcoin over the long run. This transaction showcases how we can grow Bitcoin holdings and Bitcoin per share at an unmatched pace in the industry to drive equity value accretion." Matt Cole, Chairman & CEO of Strive.
• "We believe this merger creates significant value for our stockholders by delivering a substantial premium and direct participation in one of the most innovative Bitcoin strategies in the public markets. Just as importantly, this merger can drive shareholder value by expanding our medical diagnostics business into a robust preventative care and wellness platform focused on early detection of chronic disease. This dual-pronged strategy fuels both financial strength and mission-driven growth opportunities for our stakeholders." Eric Semler, Executive Chairman of Semler Scientific.

Industry Context

This merger signifies a growing trend of publicly traded companies integrating Bitcoin into their corporate treasury strategies, moving beyond traditional asset management. By combining Strive's asset management and Bitcoin treasury focus with Semler Scientific's established medical diagnostics business, the new entity aims to create a unique dual-pronged strategy. This could set a precedent for how companies leverage diverse revenue streams to fund aggressive Bitcoin accumulation while also expanding into high-growth healthcare sectors like preventative diagnostics, potentially influencing other companies to explore similar hybrid models.

Comparison to Industry Standards

• The combined company aims to become the "fastest growing corporate Bitcoin holder," indicating an aggressive accumulation strategy compared to peers.
• Strive positions itself as a "top Bitcoin treasury company" with "alpha-seeking strategies" and a capital structure designed to "outperform Bitcoin over the long run," suggesting a differentiated approach from passive Bitcoin holders.
• The stated goal to grow "Bitcoin holdings and Bitcoin per share at an unmatched pace in the industry" implies a competitive advantage in capital deployment for Bitcoin acquisition.
• The preferred equity-only leverage model is presented as a way to avoid "debt maturity risks associated with traditional leveraged Bitcoin strategies," distinguishing its risk profile from companies using debt for Bitcoin purchases.

Management Changes

Stakeholder Impact

• Shareholders (Semler Scientific): Expected to receive a substantial premium (210% or $90.52 per share) and direct participation in Strive's Bitcoin strategy.
• Shareholders (Strive): Will experience dilution due to the issuance of new shares but are expected to benefit from equity value accretion through accelerated Bitcoin holdings growth and diversified business strategy.
• Employees: Potential for changes in business or employee relationships due to the merger, though the diagnostics business will continue with a new management team and expanded mandate.
• Customers: Potential for adverse reactions or changes to business relationships, though the diagnostics business aims to expand into preventative care, potentially offering new services.
• Creditors: The combined company plans to use a preferred equity-only leverage model, which aims to avoid debt maturity risks, potentially impacting future credit relationships by reducing reliance on traditional debt.

Next Steps

• Strive intends to file a Registration Statement on Form S-4 with the SEC to register the Class A common stock to be issued.
• A definitive Information Statement/Proxy Statement/Prospectus will be sent to Semler Scientific stockholders to seek their approval of the proposed transaction.
• Closing of the transaction is subject to the satisfaction of customary closing conditions.
• The combined company intends to explore monetizing or distributing Semler Scientific's diagnostics business at a future date.
• The combined company plans to acquire additional Bitcoin from future financings.
• The combined company will support future perpetual preferred offerings.

Key Dates

Recommendation

The proposed merger offers a substantial 210% premium to Semler Scientific shareholders, making it a highly attractive exit or conversion opportunity. For Strive, this acquisition significantly scales its Bitcoin treasury holdings to over 10,900 Bitcoin, solidifying its position as a rapidly growing corporate Bitcoin holder. The strategic shift to a preferred equity-only leverage model for Bitcoin accumulation mitigates traditional debt risks. Additionally, the expansion of Semler's profitable diagnostics business into preventative care provides a diversified and mission-driven growth avenue. This dual-pronged strategy, coupled with management's confidence in achieving unmatched growth in Bitcoin per share, presents a compelling long-term investment case for the combined entity, despite the initial dilution for existing Strive shareholders.

Keywords

Strive Inc, Semler Scientific, Bitcoin Treasury, Merger, All-Stock Transaction, ASST, SMLR, Preventative Diagnostics, Corporate Bitcoin Holdings, QuantaFlo, Medical Devices, Asset Management